Consortium at a glance
A multilateral initiative to foster the clinical development of effective malaria vaccine candidates in Africa.
MIMVaC-Africa consortium is a large interdisciplinary consortium formed by malaria vaccine developpers from academia, industry and NGO, plus clinical trial experts.
The consortium constitutes in total of ten (10) partner institutions from the world, resolutely committed to the fight against malaria through the development of malaria vaccines. The MIMVaC-Africa officially started its activities on 31 March 2020 and is coordinated by the Groupe de Rechechre Action en Santé (GRAS) based in Burkina Faso.
Workpackages
MIMVaC-Africa is organized into seven (07) work packages which implement the activities.
About Us
The MIMVaC-Africa consortium is a large interdisciplinary consortium formed by leading vaccine developpers, clinical trial experts and malaria researchers.
Governance
The MIMVaC-Africa governance is multi-layered comprising the General assembly (GA), the Project Steering Committee (PSC) and an External Independent Scientific Advisory Group (EISAG).
Latest News
Thanks for taking a little times to follow our news through these articles.
World Malaria Day: The MIMVaC-Africa initiative for an effective malaria vaccin
PRESS RELEASE World Malaria Day: The MIMVaC-Africa initiative for an effective malaria vaccine Ouagadougou, 23 April 2021. MIMVaC-Africa is a major consortium of a dozen universities and institutes around the world [...]
GRAS in Banfora for MIMVaC-Africa premises
Above all, the beginning of a field research study, important steps of local communication are necessary for the accession of all the actors. A coordination team, led by Dr. Sodiomon Sirima, [...]
World Malaria Day: The Groupe de Recherche Action en Santé (GRAS) renews its commitment to the fight against malaria.
Every 25 April, International Malaria Day is celebrated. All the actors of health and humanity, are working on this phenomenon, more than tragic, which bereaves millions of families around the world [...]
“ None of us, acting alone, can achieve the success. ”
Partners
The consortium includes many of the foremost research groups in this field:
- Europe: Eberhard Karls Universität Tübingen (EKUT), Germany; The Chancellor, the Masters and the Scholars of the University of Oxford (UOXF), UK; European Vaccine Initiative (EVI), Germany; Leiden University Medical Center (LUMC), the Netherlands; and Luxembourg Institute of Health (LIH), Luxembourg;
- Asia: Osaka University, Japan.
- Africa : Groupe de Recherche Action en Santé (GRAS), Burkina Faso ; Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon ; Fundação Manhiça, Mozambique ; Ifakara Health Institute (IHI), Tanzania.
